Physician profile
Manuel Viamonte
NPI 1033172978
$15,725.54
in general payments reported to CMS, 2019-2025
31 companies · $2,274 in 2025
The $2,274 reported for 2025 was more than what 82% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,777 · 2020: $803 · 2021: $400 · 2022: $3,069 · 2023: $5,303 · 2024: $99.49 · 2025: $2,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,188 · Food and Beverage: $887 · Travel and Lodging: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,187.50 |
| Food and Beverage | $887.44 |
| Travel and Lodging | $601.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $7,771.56 | 2019-2023 | Echelon Flex, Vistaseal |
| Ethicon US, LLC | $2,983.55 | 2019-2025 | Enseal X1, Enseal, Ethicon |
| Medtronic, INC. | $2,530.09 | 2022-2023 | Gi Genius, Interstim |
| Ovesco Endoscopy USA, INC. | $601.25 | 2023 | |
| Myriad Genetic Laboratories, INC. | $347.45 | 2021-2025 | Prolaris, Myrisk |
| Ethicon INC. | $325.00 | 2020 | |
| Northgate Technologies, INC. | $300.00 | 2020 | |
| Medtronic USA, INC. | $145.21 | 2019-2020 | |
| Allergan, INC. | $89.77 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $73.15 | 2020-2024 | Verquvo |
| Mallinckrodt Hospital Products INC. | $66.27 | 2020-2021 | |
| Innovation Technologies INC | $65.00 | 2019 | |
| Livanova USA, INC. | $64.56 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Integra Lifesciences Corporation | $51.59 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $35.53 | 2024 | Watchman Access System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $29.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $28.58 | 2023 | Wainua |
| Alnylam Pharmaceuticals INC. | $27.54 | 2023 | Onpattro |
| Celltrion USA INC. | $22.60 | 2025 | Vegzelma |
| Eisai INC. | $22.35 | 2022 | |
| Abbott Laboratories | $20.06 | 2024 | Freestyle Libre |
| Bayer Healthcare Pharmaceuticals INC. | $18.97 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.18 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.09 | 2020 | |
| Glaxosmithkline, LLC. | $16.67 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.61 | 2020 | |
| Redhill Biopharma INC. | $15.53 | 2023 | |
| Angiodynamics, INC. | $13.83 | 2023 | Nanoknife |
| Thd America, INC. | $9.70 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Viamonte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.